HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A systematic algorithm for the management of lower lip asymmetry.

AbstractPURPOSE:
An asymmetric smile, caused by loss of function of the lip depressors, can be functionally and cosmetically debilitating. Although some surgeons report excellent results with muscle transfer to the lower lip, many facial reanimation surgeons find that dynamic techniques do not consistently address the lower lip. Our objectives were to retrospectively review our outcomes after treatment of the asymmetric lower lip, and to propose a progressive, stepwise algorithm for the management of lower lip asymmetry in facial paralysis.
MATERIAL/METHODS:
Retrospective chart review was performed on all patients treated in a multidisciplinary facial nerve center with lower lip asymmetry over an eighteen month period. Treatment ranged from a temporary trial of lidocaine, to chemodenervation with botulinum toxin, to pedicled digastric muscle transfer, and/or resection of the nonparetic depressor labii inferioris (DLI).
RESULTS:
Fifty-seven patients were treated with chemodenervation with botulinum toxin, four with anterior belly of the digastric transfer, and 3 with DLI resection. All patients with DLI resection had undergone chemodenervation to the contralateral lower lip with botulinum toxin and were pleased with the appearance of their smile.
CONCLUSIONS:
We have found that lower lip asymmetry is optimally managed by adherence to a standardized protocol that offers patients insight into the likely outcome of chemodenervation or surgery and progresses systematically from the reversible to the irreversible. We present our algorithm for the management of the asymmetric lower lip, which reflects this graduated approach and has resulted in high patient satisfaction.
AuthorsRobin W Lindsay, Colin Edwards, Chris Smitson, Mack L Cheney, Tessa A Hadlock
JournalAmerican journal of otolaryngology (Am J Otolaryngol) 2011 Jan-Feb Vol. 32 Issue 1 Pg. 1-7 ISSN: 1532-818X [Electronic] United States
PMID20015805 (Publication Type: Journal Article)
CopyrightPublished by Elsevier Inc.
Chemical References
  • Neuromuscular Agents
  • Botulinum Toxins
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Algorithms
  • Botulinum Toxins (therapeutic use)
  • Facial Asymmetry (physiopathology, therapy)
  • Facial Paralysis (physiopathology, therapy)
  • Female
  • Humans
  • Lip Diseases (physiopathology, therapy)
  • Male
  • Middle Aged
  • Muscle, Skeletal (transplantation)
  • Neuromuscular Agents (therapeutic use)
  • Recovery of Function
  • Retrospective Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: